MiR‐200c‐3p and miR‐485‐5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non–small cell lung cancer cells through targeting RRM2

BACKGROUND: This study intended to investigate the potential mechanism of microRNA‐200c‐3p (miR‐200c‐3p) and miR‐485‐5p in mediating the cisplatin (DDP) resistance in non–small cell lung cancer (NSCLC). METHODS: Quantitative real‐time polymerase chain reaction (qRT‐PCR) was applied to measure the ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Zhang, Yong, Li, Qiubo, Xu, Ruiqi, Huang, Nian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250847/
https://www.ncbi.nlm.nih.gov/pubmed/35599447
http://dx.doi.org/10.1111/1759-7714.14475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250847/
https://www.ncbi.nlm.nih.gov/pubmed/35599447
http://dx.doi.org/10.1111/1759-7714.14475

Ejemplares similares